Effect of Afsanteen (Artemisia Absinthium L.) In Treatment of Fatty Liver Disease

Phase 3

Recruiting

Conditions: on Alcholic Fatty liver.
K76.0
Fatty (cha

Registration Number: IRCT20190415043279N12

Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 56

Inclusion Criteria

Patients with aminotransferases greater than 1.5 times the normal maximumUltrasound images with Stage 2, 3
Ultrasound images with Stage 2, 3

Exclusion Criteria

Pregnancy
Lactation
Alcohol consumption (more than 140 cc in men and 70 cc in women per week)
Viral hepatitis
Diabetic patients
Patients taking drugs that affect the liver enzymes
Patients taking anticoagulants
People with a history of bleeding and hemostatic disorders
Patients with allergies to herbs and herbal remedies

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alanine Aminotransferase (ALT). Timepoint: At baseline and end of the study. Method of measurement: Using biochemical method and Pars azmoon Company's Kit.;Aspartate Aminotransferase (AST). Timepoint: At baseline and end of the study. Method of measurement: Using biochemical method and Pars azmoon Company's Kit.;Alkaline Phosphatase (ALP). Timepoint: At baseline and end of the study. Method of measurement: Using biochemical method and Pars azmoon Company's Kit.;Gamma glutamine transferase (GGT). Timepoint: At baseline and end of the study. Method of measurement: Using biochemical method and Pars azmoon Company's Kit.;Bilirubin. Timepoint: At baseline and end of the study. Method of measurement: Using biochemical method and Pars azmoon Company's Kit.;Grade of fatty liver. Timepoint: At baseline and end of the study. Method of measurement: Sonography.;Body Mass Index (BMI). Timepoint: At baseline and end of the study. Method of measurement: by measuring height and weight using a scale and height meter.

Secondary Outcome Measures